Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 98

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 98
---
1,006,106 Ordinary Shares upon the automatic conversion of the 1,006,106 Preferred Shares issued and outstanding as of the date hereof, which will automatically convert upon the completion of this offering at a 1:1 ratio; (ii) the issuance of 243,955 Ordinary Shares upon the automatic conversion of the $900,000 outstanding principal of 2020 CLAs, which will occur upon the completion of this offering; and (iii) the issuance of 221,456 Ordinary Shares upon the automatic conversion of the $450,000 outstanding principal of 2024 CLAs, which will occur upon the completion of this offering.

After giving effect to the additional issuance of the sale of Ordinary Shares in this offering at an assumed initial public offering price of $ per Ordinary Share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, but assuming no exercise of the Representative’s Warrant, our pro forma as adjusted net tangible book value at June 30, 2024 would have been $ per Ordinary Share. This represents an immediate increase in pro forma as adjusted net tangible book value of $ per share to existing shareholders and immediate dilution of $ per Ordinary Share to new investors. The following table illustrates this dilution per Ordinary Share:

| Assumed public offering price per Ordinary Share                                                        |     | $ |         |   |
| Historical net tangible book value per share as of ‌ June ‌30, 2024                                     |     |   | (596.47 | ) |
| Increase in net tangible book value per share attributable to the pro forma adjustments described above |     |   |  595.79 |   |
| Pro forma net tangible book value per share as of ‌ June ‌30, 2024                                      |     |   |   (0.68 | ) |
| Increase in net tangible book value per share attributable to new investors                             |     |   |         |   |
| Pro forma as adjusted net tangible book value per share after this offering                             |     |   |         |   |
| Dilution per share to new investors                                                                     |     |   |         |   |
| Percentage of dilution in net tangible book value per share for new investors                           |     |   |         |   |

The pro forma and pro
forma as adjusted information is illustrative only, and we will adjust this information based on the actual initial public offering